The metabolism of neutral fucose-containing glycosphingolipids has become an increasingly important area of investigation because of their presence in erythrocytes (3) (4) (5) (6) (7) (8) (9) (10) , dog small intestine (11) , hog gastric mucosa (12) , bovine liver (13) , and plasma membranes of primate cell surfaces (14) . Fucolipids containing sialic acid have been isolated from boar testis (15) and human kidney (16) . Accumulation of short-chain fucolipids and an associated deletion of long-chain fucolipids in oncornavirus-transformed baboon and human embryonic cell lines were observed by Steiner et al. (17) . Recently a blood group H-I active fucolipid was isolated from rat ascites hepatoma AH7974F (18) . Isolation of a-L-fucosylceramide (19) and a novel Lea-type fucolipid (20) from human colon tumor and adenocarcinoma, respectively, suggests the occurrence of metabolic control of neutral fucolipids during malignancy or differentiation of higher primate cells (21) .
Because specific glycosyltransferases are involved in the biosynthesis in vitro of fucose-containing glycolipids (14, (21) (22) (23) (24) (25) (26) and glycoproteins (27) (28) (29) , changes in the level of activities of these glycolipid:glycosyltransferases may be correlated during tumorigenesis or chemically induced differentiation of tumor cells of higher primate origin. It has been reported recently (30, 31) that glycoprotein:fucosyltransferase activities in human plasma increase substantially during tumor progression and the development of metastases. Knowledge of the biosynthesis in vitro of specific fucolipids in cultured tumor or differentiated cells of human origin has been limited until now (21) .
The present report is concerned primarily with the stepwise biosynthesis in vitro of blood groups H-I and B-I and an intermediate of the novel Lea-type fucolipid in undifferentiated and chemically [BrdUrd or 6-mercaptoguanosine (sGuo)] differentiated human neuroblastoma (IMR-32) cells (32) . Specific clones of mouse neuroblastoma cells are known to undergo significant morphological changes (i.e., neurite formation) in the absence of serum (33) (14) . The B-active pentaglycosylceramide,
, was isolated from rabbit erythrocytes (22) .
(LcOse3-Cer) and neolactotetraosylceramide [Gal(,B1-4)-GlcNAc(f31-3)Gal(f31-4)Glc-Cer] (nLcOse4-Cer) were prepared from the rabbit lactopentaosylceramide by sequential degradation of terminal galactose units with purified fig a-galactosidase and papaya fl-galactosidase. The glycosidases were purifed according to described methods (14) . The purified glycosphingolipids were analyzed by gas/liquid chromatography (22) and mass spectrometry. Mass spectral data were interpreted according to Bjorndal et al. (39) . BrdUrd and sGuo were purchased from Sigma Chemical Co.
Cell Culture. Control cultures of human neuroblastoma clone IMR-32 (purchased from American Type Culture Collection) were maintained at 370 in 250-ml (75 cm2) Falcon plastic flasks containing 15 ml of Dulbecco's modified Eagle's minimal essential medium supplemented with 10% fetal calf serum and 10% horse serum (Gibco), in a humidified atmosphere of 90% air/10% CO2. The medium was changed three times a week. When monolayers reached confluence, the cells were subcultured by using Ca2+-and Mg2+-free phosphate-buffered saline (7.0 mM potassium phosphate/0. 14 M NaCl) containing 0.1% EDTA, pH 7.2. Cells were harvested by using this same mixture, and membrane fractions for glycolipid:glycosyltransferase assays were isolated at the junction of 0.32 M and 1.2 M on a discontinuous sucrose density gradient (14, 40) .
Glycolipid Glycosyltransferase Assays. Complete incubation mixtures for the glycolipid a-fucosyltransferase assay Abbreviations: sGuo, 6-mercaptoguanosine; (But)2cAMP, N6,02'-dibutyryladenosine cyclic-3',5'-monophosphoric acid; LcOse2-Cer, lactosylceramide; LcOse3-Cer, lactotriaosylceramide; LcOse4-Cer, lactotetraosylceramide; nLcOse4-Cer, neolactotetraosylceramide; nLcOse5-Cer, neolactopentaosylceramide.
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The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Human neuroblastoma IMR-32 clone was maintained on Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 10% horse serum (Gibco). Cultures were grown in Falcon T flasks (75 cm2). At half-confluence, the medium was changed and the cells were maintained for the indicated periods on a new medium containing 4 MM BrdUrd and L-[14C]fucose (20,000 dpm/ml). The cells were washed with cold Ca2+_ and Mg2+-free phosphate-buffered saline (pH 7.2) and harvested with the same buffer containing 0.1% EDTA. An aliquot was filtered through Whatman borosilicate paper (GF/A; 2.4 cm; 1 ,m porosity) on a Millipore apparatus. The cells that adhered to the discs were washed with 15 ml of cold 5% trichloroacetic acid or 5% trichloroacetic acid followed by 15 ml of chloroform/ methanol (2:1) for determination of [14C]fucose incorporation into glycoprotein (retained on GF/A paper) or glycolipid, respectively. The glass fiber discs were dried at 1000, and the radioactivity was assayed in a toluepe liquid scintillator system with a Beckman LS-3133T scintillation counter. Each value is the mean of duplicate experiments. a 30-hr incubation and to a maximum of 46% by 72 hr of incubation in the presence of 4 ,uM BrdUrd. A significant decrease (85%) in glycolipid biosynthesis was observed under similar conditions. There was almost a 2-fold increase in both glycoprotein and glycolipid when the cells were differentiated in the presence of sGuo for 72 hr (Fig. 2) .
The levels of glycolipid a-fucosyltransferase activity were also compared in cells treated with sGuo, with neolactotetraosylceramide and lactopentaosylceramide as acceptors ( Table  4 ). The a(1,2)fucosyltransferase level did not change significantly, with respect to control values, during differentiation of the human IMR-32 clone in the presnece of sGuo.
Isolation and Characterization of "4C-Labeled Products. The labeled products were isolated from large-scale (40-to 100-fold) incubation mixtures with lactopentaosylceramide and lactotriaosylceramide as substrates. The radioactive products were first separated by a double chromatographic method as Eagle's medium containing 4 ,AM sGuo and L-[14C]fucose (20,000 dpm/ml) for the indicated times. The incorporation of [14C]fucose into glycolipid and glycoprotein was quantitated by the method described in Table 3 . Untreated cells: a, trichloroacetic acid wash; o, trichloroacetic acid followed by chloroform/methanol wash. Treated cells: *, trichloroacetic acid wash, El, trichloroacetic acid followed by chloroform/methanol wash. The complete incubation mixtures contained the same components as described for glycolipid glycosyltransferase assays except that the indicated substrates were used in the incubation mixtures and cells treated with 4 AtM sGuo for 72 hr were used as enzyme source for the values given in the last column.
described for glycolipid glycosyltransferase assays. The radioactive product was eluted from Whatman 3MM paper with chloroform/methanol/water, 60:35:8 (vol/vol), dried, and applied to a Unisil column. 14C-Labeled products were eluted with increasing concentrations of methanol as described (24) . The thin-layer chromatographic migrations of the two enzymatic products obtained with lactotriaosylceramide and lactopentaosylceramide as acceptors indicated that these products were [14C]fucose-containing tetraglycosylceramide (lane 2, (22) . (Table 4) . However, the a (1,3) or a(1,4) fucosyltransferase that catalyzed the transfer of L-fucose from GDP-L-[14C]fucose to lactotriaosylceramide was different from the one that catalyzed the synthesis of H-I or B-I glycosphingolipids, as shown by the 10-fold increase in its activity in isolated membranes of IMR-32 cells (Table 1) .
Species-specificity studies revealed ( (47) . Recently, Sundsmo and Hakomori (48) reported on the relatively high content of neolactotetraosylceramide in DNA virally transformed NIL hamster cell surfaces compared with nontransformed cells. The evidence presented in this paper suggests that in lower animals (e.g., mouse neuroblastoma) the lactotriaosylceramide is converted to nonfucose-containing pentaglycosylceramide (Fig. 4) whereas in higher primate cells (e.g., human neuroblastoma) it can be converted to either H-I or B-I type fucose-containing glycosphingolipids.
